Pregabalin Sandoz

Riik: Euroopa Liit

keel: inglise

Allikas: EMA (European Medicines Agency)

Osta kohe

Infovoldik Infovoldik (PIL)
22-11-2023
Toote omadused Toote omadused (SPC)
22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
16-07-2015

Toimeaine:

pregabalin

Saadav alates:

Sandoz GmbH

ATC kood:

N03AX16

INN (Rahvusvaheline Nimetus):

pregabalin

Terapeutiline rühm:

Antiepileptics,

Terapeutiline ala:

Anxiety Disorders; Neuralgia; Epilepsy

Näidustused:

Neuropathic painPregabalin Sandoz is indicated for the treatment of peripheral and central neuropathic pain in adults.EpilepsyPregabalin Sandoz is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.Generalised Anxiety DisorderPregabalin Sandoz is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Toote kokkuvõte:

Revision: 17

Volitamisolek:

Authorised

Loa andmise kuupäev:

2015-06-19

Infovoldik

                                71
B. PACKAGE LEAFLET
72
PACKAGE LEAFLET: INFORMATION FOR THE USER
PREGABALIN SANDOZ 25 MG HARD CAPSULES
PREGABALIN SANDOZ 50 MG HARD CAPSULES
PREGABALIN SANDOZ 75 MG HARD CAPSULES
PREGABALIN SANDOZ 100 MG HARD CAPSULES
PREGABALIN SANDOZ 150 MG HARD CAPSULES
PREGABALIN SANDOZ 200 MG HARD CAPSULES
PREGABALIN SANDOZ 225 MG HARD CAPSULES
PREGABALIN SANDOZ 300 MG HARD CAPSULES
pregabalin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects , talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1. What Pregabalin Sandoz is and what it is used for
2. What you need to know before you take Pregabalin Sandoz
3. How to take Pregabalin Sandoz
4. Possible side effects
5. How to store Pregabalin Sandoz
6. Contents of the pack and other information
1.
WHAT PREGABALIN SANDOZ IS AND WHAT IT IS USED FOR
Pregabalin Sandoz belongs to a group of medicines used to treat
epilepsy, neuropathic pain and
Generalised Anxiety Disorder (GAD) in adults.
PERIPHERAL AND CENTRAL NEUROPATHIC PAIN:
Pregabalin Sandoz is used to treat long lasting pain caused
by damage to the nerves. A variety of diseases can cause peripheral
neuropathic pain, such as diabetes
or shingles. Pain sensations may be described as hot, burning,
throbbing, shooting, stabbing, sharp,
cramping, aching, tingling, numbness, pins and needles. Peripheral and
central neuropathic pain may
also be associated with mood changes, sleep disturbance, fatigue
(tiredness), and can have an impact
on physical and social functioning and overall quality of life.
EPILEPSY:
Pregabalin Sandoz is used to treat a certain form of epilepsy (parti
                                
                                Lugege kogu dokumenti
                                
                            

Toote omadused

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Pregabalin Sandoz 25 mg hard capsules
Pregabalin Sandoz 50 mg hard capsules
Pregabalin Sandoz 75 mg hard capsules
Pregabalin Sandoz 100 mg hard capsules
Pregabalin Sandoz 150 mg hard capsules
Pregabalin Sandoz 200 mg hard capsules
Pregabalin Sandoz 225 mg hard capsules
Pregabalin Sandoz 300 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pregabalin Sandoz 25 mg hard capsules
Each hard capsule contains 25 mg of pregabalin.
Pregabalin Sandoz 50 mg hard capsules
Each hard capsule contains 50 mg of pregabalin.
Pregabalin Sandoz 75 mg hard capsules
Each hard capsule contains 75 mg of pregabalin.
Pregabalin Sandoz 100 mg hard capsules
Each hard capsule contains 100 mg of pregabalin.
Pregabalin Sandoz 150 mg hard capsules
Each hard capsule contains 150 mg of pregabalin.
Pregabalin Sandoz 200 mg hard capsules
Each hard capsule contains 200 mg of pregabalin.
Pregabalin Sandoz 225 mg hard capsules
Each hard capsule contains 225 mg of pregabalin.
Pregabalin Sandoz 300 mg hard capsules
Each hard capsule contains 300 mg of pregabalin.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard capsule.
Pregabalin Sandoz 25 mg hard capsules
Pale yellow-brown opaque cap and body, capsule size 4 (14.3 mm x 5.3
mm), filled with white to
nearly white coloured powder.
Pregabalin Sandoz 50 mg hard capsules
Light yellow opaque cap and body, capsule size 3 (15.9 mm x 5.8 mm),
filled with white to nearly
white coloured powder.
Pregabalin Sandoz 75 mg hard capsules
Red opaque cap and white opaque body, capsule size 4 (14.3 mm x 5.3
mm), filled with white to
nearly white coloured powder.
3
Pregabalin Sandoz 100 mg hard capsules
Red opaque cap and body, capsule size 3 (15.9 mm x 5.8 mm), filled
with white to nearly white
coloured powder.
Pregabalin Sandoz 150 mg hard capsules
White opaque cap and body, capsule size 2 (18.0 mm x 6.4 mm), filled
with white to nearly white
coloured powder.
Pregabalin Sandoz 200 mg hard capsules
Pale
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik bulgaaria 22-11-2023
Toote omadused Toote omadused bulgaaria 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande bulgaaria 16-07-2015
Infovoldik Infovoldik hispaania 22-11-2023
Toote omadused Toote omadused hispaania 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande hispaania 16-07-2015
Infovoldik Infovoldik tšehhi 22-11-2023
Toote omadused Toote omadused tšehhi 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande tšehhi 16-07-2015
Infovoldik Infovoldik taani 22-11-2023
Toote omadused Toote omadused taani 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande taani 16-07-2015
Infovoldik Infovoldik saksa 22-11-2023
Toote omadused Toote omadused saksa 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande saksa 16-07-2015
Infovoldik Infovoldik eesti 22-11-2023
Toote omadused Toote omadused eesti 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande eesti 16-07-2015
Infovoldik Infovoldik kreeka 22-11-2023
Toote omadused Toote omadused kreeka 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande kreeka 16-07-2015
Infovoldik Infovoldik prantsuse 22-11-2023
Toote omadused Toote omadused prantsuse 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande prantsuse 16-07-2015
Infovoldik Infovoldik itaalia 22-11-2023
Toote omadused Toote omadused itaalia 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande itaalia 16-07-2015
Infovoldik Infovoldik läti 22-11-2023
Toote omadused Toote omadused läti 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande läti 16-07-2015
Infovoldik Infovoldik leedu 22-11-2023
Toote omadused Toote omadused leedu 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande leedu 16-07-2015
Infovoldik Infovoldik ungari 22-11-2023
Toote omadused Toote omadused ungari 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande ungari 16-07-2015
Infovoldik Infovoldik malta 22-11-2023
Toote omadused Toote omadused malta 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande malta 16-07-2015
Infovoldik Infovoldik hollandi 22-11-2023
Toote omadused Toote omadused hollandi 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande hollandi 16-07-2015
Infovoldik Infovoldik poola 22-11-2023
Toote omadused Toote omadused poola 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande poola 16-07-2015
Infovoldik Infovoldik portugali 22-11-2023
Toote omadused Toote omadused portugali 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande portugali 16-07-2015
Infovoldik Infovoldik rumeenia 22-11-2023
Toote omadused Toote omadused rumeenia 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande rumeenia 16-07-2015
Infovoldik Infovoldik slovaki 22-11-2023
Toote omadused Toote omadused slovaki 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande slovaki 16-07-2015
Infovoldik Infovoldik sloveeni 22-11-2023
Toote omadused Toote omadused sloveeni 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande sloveeni 16-07-2015
Infovoldik Infovoldik soome 22-11-2023
Toote omadused Toote omadused soome 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande soome 16-07-2015
Infovoldik Infovoldik rootsi 22-11-2023
Toote omadused Toote omadused rootsi 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande rootsi 16-07-2015
Infovoldik Infovoldik norra 22-11-2023
Toote omadused Toote omadused norra 22-11-2023
Infovoldik Infovoldik islandi 22-11-2023
Toote omadused Toote omadused islandi 22-11-2023
Infovoldik Infovoldik horvaadi 22-11-2023
Toote omadused Toote omadused horvaadi 22-11-2023
Avaliku hindamisaruande Avaliku hindamisaruande horvaadi 16-07-2015

Otsige selle tootega seotud teateid

Vaadake dokumentide ajalugu